Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · December 27, 2022

Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse

Inflammatory Bowel Diseases

 

Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse
Inflamm. Bowel Dis. 2022 Nov 02;28(11)1709-1716, J Park, SJ Kang, H Yoon, J Park, HJ Oh, HY Na, HS Lee, CM Shin, YS Park, N Kim, DH Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading